A Double-blind, Triple Dummy, Placebo-controlled, Randomised, Parallel Group Positron Emission Tomography Study to Investigate the Effects of a 8 Week Administration of GW597599 and Paroxetine Either Alone or in Combination on Regional Cerebral Blood Flow During a Public Speaking Test in Subjects Affected by Social Phobia.
Phase of Trial: Phase II
Latest Information Update: 26 Sep 2016
At a glance
- Drugs Paroxetine; Vestipitant
- Indications Social phobia
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 12 Oct 2006 New trial record.